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1. Introduction 
Bacterial Meningitis is a leading cause of childhood Deafness in Ghana and the sub- Saharan 
Africa. Children are predominantly at risk of bacterial meningitis mainly because of their 
immature immune system, and malnutrition especially in our part of the world. Lack of 
immunization practices also makes them more susceptible to significantly high morbidity 
and mortality. 
Even with the provision of highly effective antibiotic therapy, death and long-term 
disabilities are the common but still serious consequences of acute bacterial meningitis in 
developing countries. 
Common neurological complications in both adult and children are motor deficit, cognition 
deficit, hemiplegia, epilepsy, developmental and learning disabilities, blindness and 
Deafness. 
In this chapter, we shall focus more on the devastating effects of sensorineural Hearing loss 
or Deafness, after bacterial meningitis. Delay in the Diagnosis of Hearing loss occurs firstly 
because language development of Hearing impaired children, parallels that of normal 
infants till the age of nine months. Secondly, because children with profound hearing loss 
coo and bable until this age, the parents are likely to ignore any subtle evidence of hearing 
impairment such as lack of response to environmental sound. Damage to the Cochlea, 
occurs in the early stages of the illness and it is often permanent and irreversible. Woodrow 
& Brobby (1997); Daya et al. (1998). 
Prevention of deafness relies on early treatment with appropriate antibiotics, but adjunctive 
treatment with dexametnasore though controversial may be useful in preventing the sequel 
of sensorineural Hearing loss. In the long term vaccinations may be the most practicable 
means to reducing the burden of meningitis in the developing countries of Africa. 
Facilities for audiological assessment and management of children recovering from 
meningitis are crucial for the detection of significant hearing impairment and the 
implementation of rehabilitation programmes. 
www.intechopen.com
 
Meningitis 
 
2 
Our observation at our University Teaching Hospital (KATH) is that about 20% of patients 
who survive with neurological sequelae, permanent sensorineuraal Hearing loss, accounts 
for approximately 75% of these cases. 
In a study on causes of Deafness in Ghana, Brobby (1998) Meningitis was rated the 3rd 
amongst other childhood infections. Recent observations predict that meningitis has taken 
the 2nd position after measles. 
This is worrying because even a mild hearing loss of less than 40 Db may have long-term 
developmental consequences. Given the scale of this problem, there is the need to review 
critically our knowledge about the natural history of the hearing loss which may follow 
meningitis and to discuss the applicability of recent therapeutic interventions studied in 
industrial nations to the diseases in the African contest. 
2. Microbiology  
In Africa, acute bacterial meningitis has an overall annual endemic rate in the region of 10-
50 per 105 populations, a figure at least 10 times that for Europe and the United States, and 
this disparity appears to be growing. Fortnum (1992). More than 70 per cent of cases are 
caused by either Streptococcus pneumonia (pneumococcal) or Neisseria meningitides 
(meningococcal). Haemophius influenza type b (Hib) is responsible for fewer cases in the 
population as a whole although it is a major problem in children less than 12 months of age, 
Airede (1993). 
Epidemics of meningococcal meningitis sweep through the sub-Saharan ‘meningitis belt’ 
every 8 to 12 years. Annual incidence may reach 1 per cent of the population in certain 
areas. 
Although this review concentrates on acute bacterial meningitis in Ghana, tuberculous 
meningitis is also relatively common in certain areas and is the leading cause of meningitis 
in the Western Cape Province of South Africa, where deafness. Deafness is a well-
recognized complication. From our experience, viral meningitis has only rarely been 
associated with deafness. 
In Africa seasonal outbreaks and epidemics of meningecal meningitis and septicaemia, 
numerically represent their greatest public health impact on the continent. 
In Ghana, the three polysaccharide encapsulated bacteria for which licensed vaccines are 
curable are Pneumococcus, Haemophilus influenza type b (Hib) and the Neisseria 
Menigococcus. Our observation is that Haemophilus influenza type b is responsible for 
fewer cases of meningitis in our sub-region. 
3. Epidemiology  
A number of factors appear to influence the frequency of post-meningitis hearing loss but it 
is not possible to predict hearing loss accurately in individual cases. Factors affecting this 
figure including the causative organism, the pneumococcus causing the highest rate of 
deafness (31.8 per cent) in comparison with the meningococcus (7.5 per cent) and Hib (11.4 
per cent) All ages may develop deafness – the fact that most cases occur in infants may 
reflect their greater susceptibility to severe infection rather than a particular vulnerability to 
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hearing impairment. At a community level, meningitis is one of the most common causes of 
hearing loss. In Kumasi, Ghana, meningitis is responsible for 8.5 per cent of cases of 
sensorineural hearing impairment in children.Brobby (1998) 
4. Natural history 
Sensorineural heating loss is typically bilateral, and occurs within 48 hours of the 
development of meningitis, with the majority of children who go on to suffer permanent 
damage having abnormal hearing tests on admission to hospital. There appears to be an 
initial phase of mild, reversible damage. Significant sensorineural hearing loss persisting 
after the acute phase of the illness is characteristically permanent although cases of partial 
recovery have been documented on certain occasions. Mild, temporary, conductive deficits 
are common in the recovery phase. Pathological correlates for these clinical findings are still 
lacking but potential pathophysiological mechanisms are discussed below.DAYA et al 
(1997) 
5. Pathology 
The auditory lesion in post-meningitic hearing loss remains obscure. It is likely that more 
than one mechanism of auditory pathway damage occurs. A body of clinical and 
experimental evidence suggests that the cochlea is the most frequent site of sensorineural 
damage, bacteria gaining access to the labyrinth via the cochlear aqueduct. DAYA et al 
(1998) Cell wall components directly toxic to cochlear hair cells, setting up a serous 
labyrinthitis In addition, these components also stimulate the inflammatory response, 
leading to suppurative labyrinthitis and permanent damage; in severe cases the labyrinth 
may be completely obliterated and neo-ossification occurs. The vestibular apparatus is 
commonly damaged in conjunction with this process. Other potential mechanisms of 
deafness include septic thrombophlebitic or embolisation of blood vessels supplying the 
inner ear and damage to the VIIIth cranial never or central auditory pathways.  
6. Diagnosis 
Screening for deafness during hospitalization is an accurate predictor of hearing impairments 
at follow-up, and ideally should be performed on all cases. It is also important to examine the 
middle ear with tympanometry in order to assess conductive impairments, which can be 
expected to improve with time. A follow-up assessment at approximately 6 weeks, when acute 
inflammation has subsided, confirms the degree of sensorineural damage and allows 
appropriate rehabilitation to be instituted. Assessment of hearing loss following meningitis is 
currently based on audiometric methods. Unfortunately the inaccuracy of age-appropriate 
tests in healthy children, the infants’ lack of consistent response to sound and the effect of 
associated motor disorders tend to impair the validity of audiometry. More objective methods 
such as Brainstem Audiometry Evoked Responses (BAERs) and Oto-Acoustic Emissions 
(OAEs) have yet to reach the clinic in most parts of the continent. 
More objective methods such as Brainstean Auditory Evoked responses (BAERs) and Oto-
Acustic Emulsions (OAEs) are the latest state of the art equipments for this purpose. (DAYA 
et, al 1998)  
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Fortunately, the Kumasi Hearing Assessments Centre established through the magnificent 
generosity of the Commonwealth Society for the Deaf is the only centre, recognized by the 
WHO, in Africa, South of the Sahara which has all these facilities. 
7. Acute management 
Prompt Empirical antibiotic treatment should include Agents active agent all main 
pathogens for the eradication of the infecting organism in order to ensure optimal 
outcome. The introduction of sulphonamides in the 1950s (primarily for meningococcal 
meningitis) and of penicillins in the 1960s had a striking effect on incidence of mortality 
and mobility. The spread of plasmid-borne betalactamases in Hib led to the addition of 
chloramphenicol to therapy. This combination is still standard in most African countries. 
The latest challenge to this regimen has been the relatively recent appearance of 
penicillin-resistant pneumococci and meningococci. Further, some pneumococci are also 
chloramphenicol-resistant. This will undoubtedly affect the choice of antibiotics although 
the number of studies documenting a worsening clinical outcome is still small. In Europe 
and the USA third-generation cephalosporins have become first-line therapy but while 
these drugs remain relatively expensive, it is probably reasonable for most African 
hospitals to continue with the combination of a penicillin and chloramphenicol as initial 
therapy as long as clinicians are aware of the risk of recrudescence, particularly if steroids 
are being used. Friedland 1998. 
A large number of clinical trials have been performed addressing the issue of whether 
steroids reduce the frequency of adverse outcomes, particularly hearing loss. It is not 
possible to discuss these studies in detail here, but certain points should be borne in mind 
when considering the evidence for and against steroids. Most trials could be criticized on 
methodological grounds because data were analysed without pre-defined end-points, 
allowing multiple comparisons to be made. In the three trials where significant results 
have been obtained, there were unusually high incidences of adverse outcome in the 
placebo group. Furthermore, no study with a consistent antibiotic regimen throughout 
has shown statistically significant reduction in hearing loss. Despite these problems, the 
case for giving dexamethasone in Hib meningitis is felt by many authorities to be strong. 
The role for dexamethasone in pneumococcal and meningococcal disease is at present 
unresolved. 
Many of the trials of both dexamethasone and antibiotic regimens have been performed in 
the United States, with Hib as the dominant aetiology and so considerable caution should be 
exercised when applying conclusion to the African setting A recent reported trial in Pakistan 
found no evidence that dexamethasone was beneficial and suggested that it may be 
deleterious in this setting. Quazy (1996) Airede (2008)  
The finding of different outcomes in various settings is not uncommon. There are clearly 
huge differences in terms of population, genetics, and timing of presentation, microbiology 
and general supportive care which can explain this apparent discrepancy. Giving the added 
cost of dexamethasone to the family of a patient who has already begun receiving two 
antibiotics, we feel that there is insufficient evidence at this time to recommend routine use 
of dexamethasone for acute bacterial meningitis of unknown cause. 
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Currently, the recommended empirical treatment of meningitis is ampicillin plus an 
aminoglycoside and a third generation cephalosporin. 
The use of dexamethasore remains controversial. But our experience at KATH suggests that 
initial Doses of 50mg Hydrocartison before the administration of the antibiotics help to 
reduce the occurance of Sensorineural hearing loss. 
8. Discussion  
The most common causes of bacterial Meningitis in the US, Europe and other developed 
countries since the 1980s have been the pneumococcus, Haemophilus influenza Type b, the 
meningococcus, Group B strepotococcus and Listeria monocytogenes. 
Works on neonatal meningitis have also shown to involve Strept, agalaciac, Listeria 
monocytogene, and enteric gram neg. WAS E’coli and citrobacteria spp.Delourois (2009) 
Longe (1984) Laving (2003). 
As already discussed under the epidemiology of meningitis in Africa, the three 
polysaccharide encapsulated bacteria most common in Ghana and Africa are Pheunococcus, 
Haemophilus influenza Type B and the Meningococcus. 
The global epidemiology changed drastically during the 20th century as vaccines and 
antibiotics became available to prevent and treat the deadly disease. 
Differential Diagonisis of Sensorineural Hearing loss in Ghanaian children revealed that, 
post-natal infections were the cause of about 60% of all Sensorineural Hearing loss in 
Ghanaian children, with measles leading with 30%, followed by malaria (Cerebral) with 14% 
and meningitis with 7.5%. See the Table Brobby (I986)11 (1986)1 
Recent observations have revealed that Bacterial meningitis is on the increase threatening to 
overtake cerebral malaria. 
This may be due to better management, and increased awareness and prevention of malaria 
in the sub region. 
It is interesting to note that deafness as a medical and social problem in the third world 
shows itself not very much differently from the image it portrays itself in the developed 
countries. However, in the developed countries deafness as a handicap has been made 
visible and effectively treated and prevented. 
For example, all childhood infections like Measles, Meningitis, Mumps and Malaria (the 
four MS) have been eliminated in the developed countries, by immunization. 
The main cause of Deafness in US and Europe is due to otoseclerosis and chromosomal 
anomalies. For example while as connexin 26 mutation causes only 18% of Deafness in 
Ghana; it is responsible for causing 50% and more of Sensorineural Hearing loss in US and 
Europe. Brobby (1986)12 (1998)13 Hammelman et al (2001)14 
It is important to observe that deafness remains a hidden handicap. In Africa delay in 
diagnosis is common because the vocalization of hearing impaired children parallels that of 
normal infants until the age of nine months; all children co and bubble; parents are indeed 
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likely to assume that speech is developing normally, ignoring any subtle evidence of 
hearing impatient such as lack of response to environmental sounds. 
The effect of deafness on a child is devastating. Ability to participate in school activities or 
in a community life at a level commensurate with others has been the comparative 
benchmark for quality of life across the millennia. Participation in the world be it modern 
or ancient, centres on communication. In ancient Greece, deafness represented a curse, an 
absence of intelligence, an inability to participate in community life. Throughout mediaval 
times the inability to understand or express speech meant that an individual was not 
allowed to inherit the family fortune. Being unable to speak, i.e. to communicate was not 
allowed to receive the sacraments of the Church, which reflected one of the primary 
elements of full participation in community life. It is therefore our duty as crusaders for 
the prevention of deafness to summon all efforts to encourage all Third World Countries 
to extend their programme of Immunization of the 6 killer diseases which have been 
eliminated in developed countries, Tuberculosis, Tetanus, Diphtheria, Pertusis, Measles 
and Poliomyelitis. 
The various National Governments should be made aware that Measles, Meningitis, 
Mumps, Tetanus and Rubellen, can be effectively prevented by cheap, readily available and 
non-toxic immunization.  
9. Vaccination 
In many industrialized nations Hib has been virtually eliminated by the use of a conjugated 
vaccine. Before these results can be applied in Africa the epidemiology of Hib disease 
(uncertain because of technical problems with culture, especially in the face of pre-
treatment) must be characterized. A recent vaccine trial, in which Hib epidemiology in The 
Gambia was thoroughly assessed prior to the vaccination campaign, showed 95 per cent 
efficacy against invasive Hib disease and should serve as a model for future studies. 
Mulhdlland (1997)  
At present, we are unaware of any African country which routinely vaccinates its children 
against Hib. Clearly, countries have many other health priorities, and the Hib vaccine is still 
relatively expensive although vaccination may actually be cost-effective in the long-term. 
Vaccination against group A and C meningococcal disease provides relatively short-lived 
immunity and has so far only been used to abort epidemics. Pneumococcal vaccine 
development has been hampered by the need to include a large number of serotypes.  
10. Rehabilitation 
Any sensorineural hearing loss is significant since even mild impairments may be of 
educational significance and subtle high-frequency deficits may interfere with the normal 
acquisition of language skills. Children with significant losses shuld be enrolled into a 
programme of rehabilitaition at a hearing assessment centre or a school for the deaf. 
Parental counselling is crucial for success. Most infants with even profound hearing loss 
retain some residual function, usually in the low frequencies. With early detection and 
management, this residual hearing can be harnessed by a comprehensive programme of 
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amplification and auditory training (hearing aids and batteries should be commonplace 
commodities, affordable and available even in developing countries). This approach, in 
combination with simultaneous use of lip-reading and sign language, can transform the 
environment of a hearing-impaired child from a world of isolation, confusion and 
frustration to one of hope. 
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